Biostar Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Biostar Pharmaceuticals is scheduled to report earnings on May 19, 2017, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 17	Jun 17	Mar 17	Dec 16	Sep 16
Income Statement	-
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 317.79K	$ 644.93K
Gross Profit	$ 0.00	$ 0.00	$ 0.00	$ -36.75K	$ 308.06K
EBIT	$ -77.98K	$ -1.27M	$ -968.43K	$ 6.10M	$ -1.46M
EBITDA	$ 222.27K	$ -986.71K	$ -670.61K	$ 6.33M	$ -1.06M
Net Income Common Stockholders	$ -125.19K	$ -1.31M	$ -1.01M	$ 3.39M	$ -1.56M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 364.97K	$ 407.41K	$ 483.86K	$ 173.29K	$ 659.36K
Total Assets	$ 41.43M	$ 40.78M	$ 41.49M	$ 42.50M	$ 40.56M
Total Debt	$ 2.43M	$ 2.38M	$ 2.34M	$ 2.33M	$ 2.42M
Net Debt	$ 2.06M	$ 1.97M	$ 1.86M	$ 2.15M	$ 1.76M
Total Liabilities	$ 5.28M	$ 5.29M	$ 5.31M	$ 5.62M	$ 6.53M
Stockholders Equity	$ 36.15M	$ 35.49M	$ 36.18M	$ 36.88M	$ 34.03M
Cash Flow	-
Free Cash Flow	$ -1.41K	$ 4.27M	$ 321.13K	$ 4.00M	$ 557.42K
Operating Cash Flow	$ -1.41K	$ 4.27M	$ 321.13K	$ 4.00M	$ 557.42K
Investing Cash Flow	$ -44.38K	$ -4.36M	$ 0.00	$ -6.38M	$ 0.00
Financing Cash Flow	$ 0.00	$ 0.00	$ 0.00	$ 1.69M	$ 1.89K

Currency in USD

Biostar Pharmaceuticals Earnings and Revenue History

Income Statement >

Biostar Pharmaceuticals Debt to Assets

Balance Sheet >

Biostar Pharmaceuticals Cash Flow

Cash Flow >

Biostar Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing